CNS Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
CNSP CNS Pharmaceuticals Inc
SMTC Semtech Corp
EU enCore Energy Corp
CJET Chijet Motor Co Inc
LAKE Lakeland Industries Inc
JWEL Jowell Global Ltd
SMAR Smartsheet Inc
FOXA Fox Corp
SCVFF Scotch Creek Ventures Inc
VEDU Visionary Education Technology Holdings Group Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.

Price
Delayed
$2.58
Day's Change
-0.105 (-3.92%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.72
Day's Low
2.48
Volume
(Light)

Today's volume of 89,039 shares is on pace to be much lighter than CNSP's 10-day average volume of 1,263,378 shares.

89,039

Advanced Micro Devices Inc. Stock Outperforms Competitors Despite Losses On The Day

4:37 pm ET March 10, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Advanced Micro Devices Inc. (AMD) slipped 1.62% to $82.67 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.45% to 3,861.59 and Dow Jones Industrial Average falling 1.07% to 31,909.64. This was the stock's second consecutive day of losses. Advanced Micro Devices Inc. closed $43.00 short of its 52-week high ($125.67), which the company reached on March 30th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as NVIDIA Corp. (NVDA) fell 2.01% to $229.65, Intel Corp. (INTC) rose 2.95% to $27.22, and Applied Materials Inc. (AMAT) fell 2.26% to $114.39. Trading volume (70.1 M) eclipsed its 50-day average volume of 56.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 10, 2023.

	

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

March 10, 2023 16:37 ET (21:37 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.